昊海生物科技(06826.HK)科創板發行最終中籤率為0.04134457%
格隆匯10月25日丨昊海生物科技(06826.HK)發佈公告,公司上交所科創板本次發行價格為89.23元/股,發行數量為1,780.00萬股。
回撥機制啟動前,初始戰略配售預計發行數量為249.20萬股,佔本次發行總數量的14.00%。網下初始發行數量為1,071.60萬股,約佔扣除初始戰略配售數量後發行數量的70.00%;網上初始發行數量為459.20萬股,約佔扣除初始戰略配售數量後發行數量的30.00%。
回撥機制啟動後,最終戰略配售數量為2,452,419股,佔本次發行總數量的13.78%。網下最終發行數量為9,220,581股,佔扣除最終戰略配售數量後發行數量的60.08%,佔本次發行總數量的51.80%;網上最終發行數量為6,127,000股,佔扣除最終戰略配售數量後發行數量的39.92%,佔本次發行總數量的34.42%。網上發行最終中籤率為0.04134457%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.